466 related articles for article (PubMed ID: 27544716)
21. [Genetic and phenotypic characteristics of SCN1A mutations in Dravet syndrome].
Xu XJ; Zhang YH; Sun HH; Liu XY; Jiang YW; Wu XR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):625-30. PubMed ID: 23225037
[TBL] [Abstract][Full Text] [Related]
22. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
[TBL] [Abstract][Full Text] [Related]
23. Homozygous mutations in the SCN1A gene associated with genetic epilepsy with febrile seizures plus and Dravet syndrome in 2 families.
Brunklaus A; Ellis R; Stewart H; Aylett S; Reavey E; Jefferson R; Jain R; Chakraborty S; Jayawant S; Zuberi SM
Eur J Paediatr Neurol; 2015 Jul; 19(4):484-8. PubMed ID: 25795284
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features and SCN1A gene mutation analysis of severe myoclonic epilepsy of infancy].
Zhang YH; Sun HH; Liu XY; Ma XW; Yang ZX; Xiong H; Qin J; Lin Q; Wu XR
Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):769-73. PubMed ID: 19099883
[TBL] [Abstract][Full Text] [Related]
25. Parental mosaicism in another case of Dravet syndrome caused by a novel SCN1A deletion: a case report.
Sharkia R; Hengel H; Schöls L; Athamna M; Bauer P; Mahajnah M
J Med Case Rep; 2016 Mar; 10():67. PubMed ID: 27021235
[TBL] [Abstract][Full Text] [Related]
26. Genetic epilepsies with febrile seizures plus: clinical spectrum of Polish patients with SCN1A mutation - preliminary report.
Terczyńska I; Szczepanik E; Duszyc K; Górka P; Tataj R; Hoffman-Zacharska D
Dev Period Med; 2014; 18(4):426-31. PubMed ID: 25874779
[TBL] [Abstract][Full Text] [Related]
27. Dravet syndrome and Dravet syndrome-like phenotype: a systematic review of the SCN1A and PCDH19 variants.
Rampazzo ACM; Dos Santos RRP; Maluf FA; Simm RF; Marson FAL; Ortega MM; de Aguiar PHP
Neurogenetics; 2021 May; 22(2):105-115. PubMed ID: 33937968
[TBL] [Abstract][Full Text] [Related]
28. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
Miller AR; Hawkins NA; McCollom CE; Kearney JA
Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
[TBL] [Abstract][Full Text] [Related]
29. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
[TBL] [Abstract][Full Text] [Related]
30. Novel SCN1A variants in Dravet syndrome and evaluating a wide approach of patient selection.
Surovy M; Soltysova A; Kolnikova M; Sykora P; Ilencikova D; Ficek A; Radvanszky J; Kadasi L
Gen Physiol Biophys; 2016 Jul; 35(3):333-42. PubMed ID: 27045673
[TBL] [Abstract][Full Text] [Related]
31. SCN1A gene sequencing in 46 Turkish epilepsy patients disclosed 12 novel mutations.
Usluer S; Salar S; Arslan M; Yiş U; Kara B; Tektürk P; Baykan B; Meral C; Türkdoğan D; Bebek N; Yalçın Çapan Ö; Gündoğdu Eken A; Çağlayan SH
Seizure; 2016 Jul; 39():34-43. PubMed ID: 27236449
[TBL] [Abstract][Full Text] [Related]
32. Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.
Kim HW; Quan Z; Kim YB; Cheong E; Kim HD; Cho M; Jang J; Yoo YR; Lee JS; Kim JH; Kim YI; Kim DS; Kang HC
Brain Dev; 2018 Apr; 40(4):287-298. PubMed ID: 29295803
[TBL] [Abstract][Full Text] [Related]
33. Adolescent behavioral abnormalities in a Scn1a
Bahceci D; Anderson LL; Occelli Hanbury Brown CV; Zhou C; Arnold JC
Epilepsy Behav; 2020 Feb; 103(Pt A):106842. PubMed ID: 31870807
[TBL] [Abstract][Full Text] [Related]
34. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies.
Mei D; Cetica V; Marini C; Guerrini R
Epilepsia; 2019 Dec; 60 Suppl 3():S2-S7. PubMed ID: 31904125
[TBL] [Abstract][Full Text] [Related]
35. The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome.
Aras LM; Isla J; Mingorance-Le Meur A
Epilepsy Behav; 2015 Mar; 44():104-9. PubMed ID: 25666511
[TBL] [Abstract][Full Text] [Related]
36. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
Li W; Schneider AL; Scheffer IE
Epilepsia; 2021 Sep; 62(9):2205-2217. PubMed ID: 34338318
[TBL] [Abstract][Full Text] [Related]
37. Case studies in neuroscience: a novel amino acid duplication in the NH
Angus M; Peters CH; Poburko D; Brimble E; Spelbrink EM; Ruben PC
J Neurophysiol; 2019 Nov; 122(5):1975-1980. PubMed ID: 31533007
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic factors predicting Dravet syndrome in infants with
Cetica V; Chiari S; Mei D; Parrini E; Grisotto L; Marini C; Pucatti D; Ferrari A; Sicca F; Specchio N; Trivisano M; Battaglia D; Contaldo I; Zamponi N; Petrelli C; Granata T; Ragona F; Avanzini G; Guerrini R
Neurology; 2017 Mar; 88(11):1037-1044. PubMed ID: 28202706
[TBL] [Abstract][Full Text] [Related]
39. Dravet syndrome: a genetic epileptic disorder.
Akiyama M; Kobayashi K; Ohtsuka Y
Acta Med Okayama; 2012; 66(5):369-76. PubMed ID: 23093055
[TBL] [Abstract][Full Text] [Related]
40. Not all
Sadleir LG; Mountier EI; Gill D; Davis S; Joshi C; DeVile C; Kurian MA; ; Mandelstam S; Wirrell E; Nickels KC; Murali HR; Carvill G; Myers CT; Mefford HC; Scheffer IE
Neurology; 2017 Sep; 89(10):1035-1042. PubMed ID: 28794249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
